Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Aerts

Showing results (181-190 of 360) with videos related to

Pageof 36
Sort By:
JIMD Reports|November 12, 2021
Renal involvement in a patient with the chronic visceral subtype of acid sphingomyelinase deficiency resembles Fabry diseaseEline C B Eskes, Martijn J C van der Lienden, Joris J T H Roelofs, et al.
Molecular Genetics and Metabolism|June 13, 2006
Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapyA C Vedder, J Cox-Brinkman, C E M Hollak, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II studyV Surmont, J G Aerts, E Pouw, et al.
Ultrastructural Pathology|May 12, 2010
Ultrastructural analysis of dermal fibroblasts in mucopolysaccharidosis type I: Effects of enzyme replacement therapy and hematopoietic cell transplantationJosanne Cox-Brinkman, Marius A van den Bergh Weerman, Frits A Wijburg, et al.
Journal of Inherited Metabolic Disease|June 1, 2006
CCL18: a urinary marker of Gaucher cell burden in Gaucher patientsRolf G Boot, Marri Verhoek, Mirjam Langeveld, et al.
Plos One|July 12, 2007
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kgAnouk C Vedder, Gabor E Linthorst, Gunnar Houge, et al.
Circulation. Cardiovascular Imaging|July 9, 2011
Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular functionAdrianus J Bakermans, Tom R Geraedts, Michel van Weeghel, et al.
The Journal of Biological Chemistry|March 8, 2020
Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterolHisako Akiyama, Mitsuko Ide, Yasuko Nagatsuka, et al.
The Lancet. Oncology|June 7, 2024
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 studyJoachim G Aerts, Robert Belderbos, Paul Baas, et al.
Molecular Genetics and Metabolism|July 15, 2023
Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiencyEline C B Eskes, Martijn J C van der Lienden, Barbara Sjouke, et al.
Pageof 36

Showing results (181-190 of 360) with videos related to

Sort By:
Pageof 36
JIMD Reports|November 12, 2021
Renal involvement in a patient with the chronic visceral subtype of acid sphingomyelinase deficiency resembles Fabry diseaseEline C B Eskes, Martijn J C van der Lienden, Joris J T H Roelofs, et al.
Molecular Genetics and Metabolism|June 13, 2006
Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapyA C Vedder, J Cox-Brinkman, C E M Hollak, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II studyV Surmont, J G Aerts, E Pouw, et al.
Ultrastructural Pathology|May 12, 2010
Ultrastructural analysis of dermal fibroblasts in mucopolysaccharidosis type I: Effects of enzyme replacement therapy and hematopoietic cell transplantationJosanne Cox-Brinkman, Marius A van den Bergh Weerman, Frits A Wijburg, et al.
Journal of Inherited Metabolic Disease|June 1, 2006
CCL18: a urinary marker of Gaucher cell burden in Gaucher patientsRolf G Boot, Marri Verhoek, Mirjam Langeveld, et al.
Plos One|July 12, 2007
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kgAnouk C Vedder, Gabor E Linthorst, Gunnar Houge, et al.
Circulation. Cardiovascular Imaging|July 9, 2011
Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular functionAdrianus J Bakermans, Tom R Geraedts, Michel van Weeghel, et al.
The Journal of Biological Chemistry|March 8, 2020
Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterolHisako Akiyama, Mitsuko Ide, Yasuko Nagatsuka, et al.
The Lancet. Oncology|June 7, 2024
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 studyJoachim G Aerts, Robert Belderbos, Paul Baas, et al.
Molecular Genetics and Metabolism|July 15, 2023
Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiencyEline C B Eskes, Martijn J C van der Lienden, Barbara Sjouke, et al.
Pageof 36